W8L1 Non communicable disease Flashcards

1
Q

What is non-commutable disease

A

refers to a group of conditions that are not mainly caused by an acute infection, result in long-term health consequences and often create a need for long-term treatment and care. These conditions include cancers, cardiovascular disease, diabetes and chronic lung illnesses.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Why do non-communicable diseases occur

A
  • Some conditions result from environmental factors which are evolutionarily novel (e.g. asbestos) or affect fundamental aspects of cell function (e.g. arsenic poisoning)
  • Some genetic disorders may have benefits which offset selective pressure against the disease
  • Some diseases occur mostly in the post-reproductive period, or occur very rarely in the absence of additional environmental factors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Case study #1 - cancer

A
  • Cancer is a highly heterogenous condition
  • Cancer is itself an evolutionary process, with distinct selective pressures on cancer cells driving higher cell division rates, capacity for migration, resistance to pro-apoptotic signals etc.
  • Development of cancer requires multiple mutations, meaning it becomes far more common late in life
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How heritable is cancer risk

A
  • Many cancers, especially in old age, occur without clear familial history
  • A minority of cancer types seem to be almost entirely sporadic, with no detectable genetic contribution
  • Cancers for which smoking is the main risk factor are over-represented among cancers with low heritability
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Environment-genome interactions Of cancer

A
  • Risk of esophageal cancer is strongly increased by tobacco and alcohol consumption
  • However, the extent to which an environmental agent increases cancer risk can itself be affected by genetic factors (in this case, a CYP26B1 variant)
  • The definition of a cancer risk allele is not straightforward!
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Familial cancer syndromes

A
  • Various familial cancer syndromes involve some risk of mortality before the end of the reproductive period
  • Caputo et al. (2012) analysed French families carrying BRCA mutations -slightly more than half of the families possessed unique alleles, but a small number of variants were widespread (one in 138 families, one in 137)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

other explanation of high-frequency cancer risk alleles be other than inefficient selection?

A
  • Elevated frequencies of risk alleles in some populations (e.g. BRCA1 risk alleles among east Greenlandic Inuit) may reflect founder effects
  • Possible benefits of risk alleles have also been suggested:
  • Increased reproductive success
  • Greater female embryonic survival
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Detecting selection on cancer risk alleles

A
  • Risk of prostate cancer is greatly elevated in African populations
  • As prostate cancer risk is highly heritable, a genetic contribution to this disparity is likely
  • Most risk alleles found to evolve neutrally across all studied populations
  • However, ‘hitchhiking’ with nearby beneficial alleles is sometimes seen
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Accidental cancer protection

A
  • rs7584330 - 47% higher frequency of risk allele in African populations, evidence of positive selection for protective allele in European populations
  • rs7584330 occurs close to the melanophilin gene, variants of which result in reduced skin and hair pigmentation
  • Lower prostate cancer risk in European vs. African populations in part a side-effect of selection for reduced skin pigmentation!
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Genetics of cancer outcomes

A
  • Most cancer research has focused on variation in incidence of cancer, rather than survival rates
  • How might we use this information in cancer screening and treatment?
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Case study #2 - Alzheimer’s disease

A
  • Decline on some measures of cognitive function is common in old age, but far from invariable
  • Alzheimer’s disease is usually diagnosed by analysis of cognitive function (memory, judgement, sociality), but formally requires neuronal biomarkers, i.e. deposition of β-amyloid and tau
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Inheritance of Alzheimer’s disease

A
  • Alzheimer’s disease is largely a post-reproductive disease; even early-onset Alzheimer’s is usually diagnosed after the age of 45
  • Alzheimer’s disease is highly heritable, especially in early-onset cases, though environmental effects (e.g. history of traumatic brain injury) can slow or accelerate onset
  • Mutations in APP, PSEN1 and PSEN2 were associated with Alzheimer’s disease in the 1980s and 1990s
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Amyloid precursor protein and presenilins

A

The normal function of β-amyloid is not well understood, despite the importance of formation of β-amyloid plaques in the brain in Alzheimer’s disease
* Presenilins have important developmental roles, and also interact with the amyloid precursor protein
* Therapies which reduce β-amyloid level have had little success in reversing the progression of Alzheimer’s disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

APOE genotype and Alzheimer’s risk

A
  • Mutations in APP or presenilins explains a fairly small portion of Alzheimer’s disease risk
  • Variation at apolipoprotein E (which transports cholesterol and lipids in the central nervous system) is the biggest single contributor to Alzheimer’s disease risk
  • APOE genotype has been linked to many other aspects of Alzheimer’s pathology, perhaps through effects on cholesterol, but the mechanisms involved are far from fully understood
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Alzheimer’s disease and APOE

A
  • Individuals with one or two copies of the APOE ε4 allele are at higher risk of developing Alzheimer’s disease in old age; the increase in risk may vary substantially with genetic background
  • In contrast, the APOE ε2 allele seems to have a weak protective effect
  • Analysis of chimpanzees suggests that APOE ε4 is the ancestral form, with APOE ε3 having arisen about 200000 years ago
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Evolution of APOE polymorphism

A
  • Numerous explanations for the evolution of APOE ε3 have been suggested, including adaptation to meat consumption and reverting the effects of earlier mutations which became fixed by chance
  • Both the APOE ε3 and APOE ε2 variants appear to have been under positive selection, though some studies suggest that APOE ε4 may have some benefits in individuals experiencing high parasite load
17
Q

Case study #3 - hypertension

A
  • Elevated blood pressure is not lethal in itself, but is a risk factor for heart disease, stroke and kidney failure
  • In light of more severe and more common hypertension in African-Americans compared to European-Americans, Young et al. (2005) argued that genetic susceptibility to high blood pressure is ancestral
  • A hot, low-salt environment would impose evolutionary pressure for salt retention, leading to water retention and increased blood volume
18
Q

G-protein signalling promotes hypertension

A
  • Young et al. found a particularly important role for GNB3 in hypertension risk; the risk allele results in a shortened protein which may promote vasoconstriction
  • A CYP3A5 variant common in European populations which reduces sodium absorption also slows the metabolism of some medications
19
Q

Evolutionary medicine

A
  • Better understanding of the evolutionary forces affecting disease risk has obvious promise for diagnosis and treatment
  • However, the interactions between multiple genes and environmental factors complicates prediction
  • How practical are therapies targeting specific gene variants?